PROGRESS report on therapeutic and toxic effects of combinations of isoniazid, streptomycin, and para-aminosalicylic acid; United States Public Health Service cooperative investigation of antimicrobial therapy of tuberculosis.
D010131:Aminosalicylic Acid / Q000627:therapeutic use*; D000890:Anti-Infective Agents; D007536:Isomerism; D007538:Isoniazid; D009525:Niacin; D009539:Nicotinic Acids / Q000627:therapeutic use*; D058028:Research Report; D013307:Streptomycin / Q000627:therapeutic use*; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary / Q000628:therapy*; D014481:United States; D014492:United States Public Health Service
D000890:Anti-Infective Agents; D009539:Nicotinic Acids; D009525:Niacin; D010131:Aminosalicylic Acid; D007538:Isoniazid; D013307:Streptomycin
NICOTINIC ACID ISOMERS/therapeutic use; PARA-AMINOSALICYLIC ACID/therapeutic use; STREPTOMYCIN/therapeutic use; TUBERCULOSIS, PULMONARY/therapy